Has Andrew Kim received payments from drug or device companies?

Yes. Drug and device makers reported $69,199 in general payments to Andrew Kim across 416 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Andrew Kim did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Andrew Kim come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Andrew Kim

Pain Medicine · Las Vegas, NVNPI 1417100918

Payments from drug & device makers

$69,199in general payments, 2019–2025

Across 416 payments — averaging $166.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Anika Therapeutics, Inc.$50K
AbbVie$9K
Boston Scientific$4K
Medtronic$1K
Scilex Pharmaceuticals Inc.$706
Biotronik NRO, Inc.$475
plus $5K from 49 others

What the payments were for

Travel & lodging$2502%
Food & beverage$10,74298%
Education$40%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Anika Therapeutics, Inc.	7	$49,842
AbbVie(2 entities)	24	$8,545
Boston Scientific	100	$3,594
Medtronic(2 entities)	42	$1,221
Scilex Pharmaceuticals Inc.	60	$706
Biotronik NRO, Inc.	18	$475
Vertos Medical, Inc.	8	$452
Flowonix Medical Incorporated	2	$426
Foundation Fusion Solutions, LLC	3	$345
Saluda Medical Americas, Inc.	12	$323
Vertiflex, Inc.	6	$322
Forte Bio-pharma LLC	3	$257
Abbott	11	$239
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	13	$220
Zyla Life Sciences, Inc.	19	$188
Arbor Pharmaceuticals, Inc.	9	$172
Amgen	7	$154
Organogenesis Inc.	1	$125
Nevro Corp.	3	$123
E.r. Squibb & Sons, L.L.C.	1	$116
Linvatec Corporation	1	$96
Si-bone, Inc.	5	$90
Nalu Medical, Inc.	3	$81
SPR Therapeutics, Inc	5	$81
Sentynl Therapeutics, Inc.	5	$76
Lundbeck LLC	3	$67
Pfizer	4	$60
Avanos Medical	1	$56
AstraZeneca	2	$50
Biodelivery Sciences International, Inc.	4	$50
Lilly USA, LLC	3	$48
Assertio Therapeutics, Inc.	3	$44
Globus Medical	2	$43
Collegium Pharmaceutical, Inc.	2	$43
Johnson & Johnson	2	$34
Teva Pharmaceuticals USA, Inc.	1	$32
Merz Pharmaceuticals, LLC	1	$32
Curonix LLC	2	$31
Merz North America, Inc.	1	$28
Vertex	1	$28
Redhill Biopharma Inc.	2	$26
Bayer	1	$25
Bristol Myers Squibb	1	$24
Tersera Therapeutics LLC	1	$22
Painteq LLC	1	$22
Almatica Pharma LLC	1	$20
Boehringer Ingelheim	1	$19
Biohaven Pharmaceuticals, Inc.	1	$19
Abiomed	1	$18
Merck	1	$16
Athena Bioscience, LLC	1	$15
Biohaven Pharmaceutical Holding Company Ltd.	1	$15
Protega Pharmaceutials Inc	1	$15
GRT US Holding, Inc.	1	$15
Novartis	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$69,199 in reported general payments places this provider in the 95th percentile of 101 pain medicine providers in Nevada.

See all pain medicine providers in Nevada →

Medicare billing

Part B allowed, 2024

$461,156

Medicare patients

830

Services billed

21,147

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	182	$4,039
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	116	$3,504
Morphine Sulfate ErMorphine Sulfate	29	$2,405
Lidocaine	17	$2,260
Celecoxib	42	$1,679
Oxycodone Hcl	73	$1,474
Gabapentin	109	$756
Tramadol Hcl	94	$723
Acetaminophen-CodeineAcetaminophen With Codeine	41	$543
Pregabalin	35	$413
Hydromorphone Hcl	12	$310
Baclofen	41	$234
Tizanidine Hcl	30	$201
Lorazepam	12	$156
Zolpidem Tartrate	13	$150

Paid to pharmacies, not to this prescriber.

Other pain medicine in Las Vegas

Sungkook ParkLas Vegas$34K
Kunal ParikhLas Vegas$26K
Nader HelmiLas Vegas$25K
Pouya MohajerLas Vegas$17K
David AlvaradoLas Vegas$15K
Okwuchukwu ObiLas Vegas$15K
Christopher FisherLas Vegas$13K
Neville CampbellLas Vegas$11K
Heerak KangLas Vegas$11K
Ruben AlexanderLas Vegas$10K

See the full list for Nevada →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →